Calls for greater transparency in the release of clinical trial data

September 20, 2016, University of York

Researchers have called for greater transparency in the public release of clinical trial data after a study revealed significant under-reporting of side effects in medical treatments.

The study, led by the University of York, revealed that the medical benefits are routinely reported, while the side effects are incompletely documented in peer-reviewed journal articles.

The clinical benefits of new drugs are usually tested in , in which patients are randomly assigned to receive drug or placebo, before drugs can be prescribed widely.

Adverse events, or side effects, are also routinely collected in such trials, and should be reported in scientific to give a clear picture of the benefit and risks of new treatments.

The study, published in PLOS Medicine  found that 64% of side effects would have been missed by readers looking only at published reports about the medical treatments studied.

The authors conclude that full reporting of is essential to allow patients and doctors to assess the balance between benefits and side effects of medical treatments.

Dr Su Golder, Research Fellow at the University of York's Department of Health Sciences, said: "We need more transparency.

"People need to have access to full information about the harm from medical treatments, so that they are aware of the consequences of choosing a particular treatment."

In one example, 198 deaths were recorded in clinical trials of four , and full details on the cause of death for all the participants were available from the pharmaceutical company dataset.  In the subsequent published papers only 29 deaths were fully reported.

In another example, an unpublished report documented 15 suicides in drug treated participants, but  only seven were revealed in published papers.

Dr Golder added: "There are serious concerns that the published findings represent only a small snapshot of the full dataset, and that patients and healthcare professionals may be making decisions based on incomplete information."

The study, which included collaboration with Gill Norman, University of Manchester and Yoon Loke, University of East Anglia, was funded through the National Institute for Health Research (NIHR).

Explore further: Harms reporting in trials of orlistat

Related Stories

Harms reporting in trials of orlistat

August 16, 2016
The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...

Major clinical trial led to steep declines in use of an ineffective breast cancer treatment

July 7, 2016
Many common medical treatments have never been tested in a clinical trial. A new study published in the July issue of Health Affairs highlights how evidence from trials of untested but widely used treatments can change medical ...

New study questions clinical trial data for kidney cancer drugs

September 23, 2015
When prescribing newly approved drugs, physicians rely on data from clinical trials to understand the benefits and risks of those drugs for patients. But a study published in the Journal of Oncology Practice showed that for ...

Antidepressants double the risk of aggression and suicide in children

January 27, 2016
Children and adolescents have a doubled risk of aggression and suicide when taking one of the five most commonly prescribed antidepressants, according to findings of a study published in The BMJ today.

Stem cell-based screening methods may predict heart-related side effects of drugs

September 19, 2016
Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.

Predicting potential pharma side effects

March 8, 2016
A computer program that can predict whether or not a given pharmaceutical will have worrying side effects has been developed by researchers in the USA. Md Jamiul Jahid and Jianhua Ruan of the Department of Computer Science, ...

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.